Skip to main navigation Skip to search Skip to main content

Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors—implications for early Myasthenia gravis treatment.

  • Marketa Komloova
  • , Kamil Musilek
  • , Anna Horova
  • , Ondrej Holas
  • , Vlastimil Dohnal
  • , Frank J Gunn-Moore
  • , Kamil Kuca

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2505-2509
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Publication statusPublished - 2011

Cite this